Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases Publisher Pubmed



Radi H1 ; Ferdosishahandashti E2 ; Kardar GA3 ; Hafezi N4
Authors

Source: Journal of Interferon and Cytokine Research Published:2024


Abstract

Interleukin-2 (IL-2) is a cytokine that acts in dual and paradoxical ways in the immunotherapy of cancers and autoimmune diseases. Numerous clinical trial studies have shown that the use of different doses of this cytokine in various autoimmune diseases, transplantations, and cancers has resulted in therapeutic success. However, side effects of varying severity have been observed in patients. In recent years, to prevent these side effects, IL-2 has been engineered to bind more specifically to its receptors on the cell surface, decreasing IL-2 toxicities in patients. In this review article, we focus on some recent clinical trial studies and analyze them to determine the appropriate dose of IL-2 drug with the least toxicities. In addition, we discuss the engineering performed on IL-2, which shows that engineered IL-2 increases the specificity function of IL-2 and decreases its adverse effects. Copyright 2024, Mary Ann Liebert, Inc., publishers.
Related Docs
View other Related Docs
1. The Role of Interleukin-2 in Graft-Versus-Host Disease Pathogenesis, Prevention and Therapy, Cytokine (2024)
2. Human Il-2Rα Subunit Binding Modulation of Il-2 Through a Decline in Electrostatic Interactions: A Computational and Experimental Approach, PLoS ONE (2022)
3. A Novel Nanobody-Based Immunocytokine of a Mutant Interleukin-2 As a Potential Cancer Therapeutic, AMB Express (2024)
Experts (# of related papers)
View all Related Experts
Alireza Biglari (3)
Nima Rezaei (2)
Other Related Docs
4. Human Il-2Rɑ Subunit Binding Modulation of Il-2 Through a Decline in Electrostatic Interactions: A Computational and Experimental Approach, PloS one (2022)
5. Evaluation of Metastasis Inhibition by Abd-Il-2 Compared to Human Il-2 in a Breast Cancer Mouse Model, Iranian Journal of Immunology (2024)
6. Transplantation Immune Responses: Biology, Challenges, and Opportunities Using Biomaterials, Gene Reports (2023)
7. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
8. The Role of Memory T Cells in Type 1 Diabetes: Phenotypes, Mechanisms, and Therapeutic Implications, Autoimmunity Reviews (2025)
9. Il-2Rg As a Possible Immunotherapeutic Target in Crc Predicting Poor Prognosis and Regulated by Mir-7-5P and Mir-26B-5P, Journal of Translational Medicine (2024)
10. The Multifaceted Role of the Il-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation, Journal of Immunology Research (2025)
11. Soluble and Immobilized Anti-Cd3/28 Distinctively Expand and Differentiate Primary Human T Cells: An Implication for Adoptive T Cell Therapy, Iranian Journal of Allergy# Asthma and Immunology (2022)
12. Communication Between Mast Cells and Group 2 Innate Lymphoid Cells in the Skin, Cells (2024)
13. Antagonistic Property of G2013 (Α-L-Guluronic Acid) on Gene Expression of Myd88, Tollip, and Nf-Κb in Hek293 Tlr2 and Hek293 Tlr4, Endocrine# Metabolic and Immune Disorders - Drug Targets (2019)
14. The Role of the Il-33/St2 Immune Pathway in Autoimmunity: New Insights and Perspectives, Immunological Investigations (2022)
15. Interleukins: Pathophysiological Role in Acute Pancreatitis, Archives of Medical Science (2024)
16. The Clinical Impact of Mrna Therapeutics in the Treatment of Cancers, Infections, Genetic Disorders, and Autoimmune Diseases, Heliyon (2024)
17. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)